|
NAPB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.492200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.682400E-01 |
| Normal-vs-Stage2 |
7.746200E-01 |
| Normal-vs-Stage3 |
8.379200E-01 |
| Normal-vs-Stage4 |
3.805200E-01 |
| Stage1-vs-Stage2 |
4.563200E-01 |
| Stage1-vs-Stage3 |
8.305600E-01 |
| Stage1-vs-Stage4 |
6.581000E-01 |
| Stage2-vs-Stage3 |
7.051200E-01 |
| Stage2-vs-Stage4 |
4.312600E-01 |
| Stage3-vs-Stage4 |
7.016000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.135200E-01 |
| Normal-vs-AfricanAmerican |
6.569800E-01 |
| Normal-vs-Asian |
7.208200E-01 |
| Caucasian-vs-AfricanAmerican |
9.147000E-01 |
| Caucasian-vs-Asian |
6.326600E-01 |
| AfricanAmerican-vs-Asian |
5.871600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.455200E-01 |
| Normal-vs-Female |
6.964400E-01 |
| Male-vs-Female |
9.603200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.732200E-01 |
| Normal-vs-Extreme_Weight |
1.478360E-01 |
| Normal-vs-Obese |
7.331000E-01 |
| Normal-vs-Extreme_Obese |
7.757400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.394400E-01 |
| Normal_Weight-vs-Obese |
6.274800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.252800E-01 |
| Extreme_Weight-vs-Obese |
2.176200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.390800E-01 |
| Obese-vs-Extreme_Obese |
9.566400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.308600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.447600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.053800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.617600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.497400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.454840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.119800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.264600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.606100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.794980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.730000E-01 |
| Normal-VS-Type2 PRCC |
1.631840E-02 |
| Normal-VS-KIRP CIMP |
3.494400E-01 |
| Normal-VS-Unclassified PRCC |
6.154800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.203400E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.423400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.065200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.476200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.272500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.286200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.405800E-02 |
| Normal-vs-N1 |
6.304200E-01 |
| Normal-vs-N2 |
1.074350E-01 |
| N0-vs-N1 |
1.515950E-01 |
| N0-vs-N2 |
3.576200E-01 |
| N1-vs-N2 |
2.976200E-01 |
|
|
